同济大学癌症中心于2017年5月正式揭牌成立，该中心是同济大学“十三五”建设“双一流”大学医学口三个重点建设项目之一，依托同济大学医学院和第十人民医院、肺科医院等我校各附属医院，整合现有的肿瘤临床、基础、转化研究团队，充分发挥同济医工结合优势，力争建设成为国内集临床与科研为一体、以临床为核心的具有特色和影响力的国内一流、世界知名的癌症中心。
癌症中心致力于肿瘤微环境基础与转化研究，包括肿瘤发生发展机制和转化，肿瘤代谢和免疫微环境机制研究及靶向，肿瘤治疗新靶点筛选及生物免疫治疗临床转化等。近年来，中心所属基础和临床团队在JAMA、Cell、Nature、Cancer Cell、Cell Research、Nature Communications、Developmental Cell等国际知名期刊上发表重要学术论文360余篇，10分以上论文100余篇；申请或授权专利60余项，科研转化成果1600万余；承担国家重点研发计划、科技部重大研究计划、国自然基金、上海市自然科学基金等课题百余项；并获得教育部科学技术进步一等奖、中华医学科技三等奖、上海市科学技术奖科技进步奖一等奖、高校科学研究成果自然科学奖一等奖多个科技奖项。
癌症中心重视人才队伍建设，由国家杰青、长江学者、科技部领军人才、“万人计划”获得者等优秀学科带头人领衔，先后引进和培养出国家杰青、优青、青年长江、上海市千人、启明星人才、新优青、扬帆计划获得者和超级博士后等，培养的研究生也多次获得国家奖学金、优秀毕业生等荣誉；同时积极探索国际合作，与美国纪念斯隆凯特琳癌症中心、安德森癌症中心、法国里昂高师、日本、德国等多所重点高校合作，拿到国家自然科学基金国际交流合作项目、上海市国际交流合作项目等。
The Cancer Center of Tongji University was officially inaugurated in May2017. This center is one of the key construction projects for the establishment of a "Double First-Class" medical university during the13th Five-Year Plan of Tongji University. It relies on the Tongji University School of Medicine and affiliated hospitals such as the Tenth People’s Hospital and the Pulmonary Hospital to integrate existing teams for clinical, basic, and translational cancer research. The center aims to leverage Tongji’s strengths in the integration of medicine and engineering, striving to become a leading cancer center in China that integrates clinical practice and research, with a focus on clinical care and a distinctive and influential presence recognized worldwide.
The Cancer Center is dedicated to foundational and translational research on the tumor microenvironment, including the mechanisms and translation of tumor development, tumor metabolism, and the immune microenvironment mechanisms as well as targeted therapies. It also focuses on screening new therapeutic targets for tumors and clinical translation of biological immunotherapies. In recent years, the center's basic and clinical teams have published over360 significant academic papers in prestigious international journals such as JAMA, Cell, Nature, Cancer Cell, Cell Research, Nature Communications, and Developmental Cell, including more than100 papers with an Impact Factor above10. Additionally, they have applied for or been granted over60 patents and achieved more than16 million in research translation results. The center has undertaken more than100 projects, including those from the National Key R&D Program, the Ministry of Science and Technology’s major research projects, the National Natural Science Foundation, and the Shanghai Natural Science Fund. It has also received multiple science and technology awards, including the First Prize of Scientific and Technological Progress from the Ministry of Education, the Third Prize of Chinese Medical Science and Technology, the First Prize of the Shanghai Science and Technology Progress Award, and the First Prize of the Natural Science Award for University Research Achievements.
The Cancer Center places great emphasis on talent development, led by outstanding academic leaders such as National Outstanding Young Scholars, Yangtze River Scholars, leading talents from the Ministry of Science and Technology, and recipients of the "Ten Thousand Talents Program." It has successively introduced and trained National Outstanding Young Scholars, Excellent Young Scientists, Young Yangtze River Scholars, Shanghai Thousand Talent Plan experts, Rising Stars, New Excellent Young Scholars, winners of the Sailing Plan, and Super Postdoctoral Fellows. Graduate students trained at the center have also received numerous honors, including National Scholarships and titles of Outstanding Graduates. Simultaneously, the center actively explores international collaborations with notable institutions such as the Memorial Sloan Kettering Cancer Center and the MD Anderson Cancer Center in the United States, as well as with key universities in France, Japan, and Germany. This has resulted in successful applications for international exchange and cooperation projects from the National Natural Science Foundation and the Shanghai International Exchange and Cooperation Project.
